138 related articles for article (PubMed ID: 9408311)
1. Is the presence of distant metastasis associated with c-myc amplification in gastric cancer?
Hajdú J; Kozma L; Kiss I; Szentkereszty Z; Szakáll S; Ember I
Acta Chir Hung; 1997; 36(1-4):119-21. PubMed ID: 9408311
[TBL] [Abstract][Full Text] [Related]
2. C-myc amplification and cluster analysis in human gastric carcinoma.
Kozma L; Kiss I; Hajdú J; Szentkereszty Z; Szakáll S; Ember I
Anticancer Res; 2001; 21(1B):707-10. PubMed ID: 11299830
[TBL] [Abstract][Full Text] [Related]
3. [Correlation between malignancy of gastric cancer and c-myc DNA amplification or overexpression of c-myc protein].
Nakata B; Onoda N; Chung YS; Maeda K; Nishimura S; Yashiro M; Nitta A; Kubo T; Kato Y; Sowa M
Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():176-9. PubMed ID: 7611785
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous protooncogene amplification correlates with tumor progression and presence of metastases in gastric cancer patients.
Ranzani GN; Pellegata NS; Previderè C; Saragoni A; Vio A; Maltoni M; Amadori D
Cancer Res; 1990 Dec; 50(24):7811-4. PubMed ID: 2253224
[TBL] [Abstract][Full Text] [Related]
5. DNA amplification of the c-myc and c-erbB-1 genes in a human stomach cancer.
Nomura N; Yamamoto T; Toyoshima K; Ohami H; Akimaru K; Sasaki S; Nakagami Y; Kanauchi H; Shoji T; Hiraoka Y
Jpn J Cancer Res; 1986 Dec; 77(12):1188-92. PubMed ID: 3102422
[TBL] [Abstract][Full Text] [Related]
6. [Expression, amplification and rearrangement of c-myc gene in human thyroid carcinoma].
Yang Y
Zhonghua Yi Xue Za Zhi; 1991 Jun; 71(6):304-6, 22. PubMed ID: 1667490
[TBL] [Abstract][Full Text] [Related]
7. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: a frequent, p53-independent mutation associated with improved outcome in a randomized multi-institutional trial.
Augenlicht LH; Wadler S; Corner G; Richards C; Ryan L; Multani AS; Pathak S; Benson A; Haller D; Heerdt BG
Cancer Res; 1997 May; 57(9):1769-75. PubMed ID: 9135021
[TBL] [Abstract][Full Text] [Related]
8. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
Kubokura H; Tenjin T; Akiyama H; Koizumi K; Nishimura H; Yamamoto M; Tanaka S
Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of c-myc messenger RNA in primary and metastatic lesions of carcinoma of the stomach.
Onoda N; Maeda K; Chung YS; Yano Y; Matsui-Yuasa I; Otani S; Sowa M
J Am Coll Surg; 1996 Jan; 182(1):55-9. PubMed ID: 8542090
[TBL] [Abstract][Full Text] [Related]
10. Protein expression and molecular analysis of c-myc gene in primary breast carcinomas using immunohistochemistry and differential polymerase chain reaction.
Naidu R; Wahab NA; Yadav M; Kutty MK
Int J Mol Med; 2002 Feb; 9(2):189-96. PubMed ID: 11786932
[TBL] [Abstract][Full Text] [Related]
11. Determination of c-myc amplification and overexpression in breast cancer patients: evaluation of its prognostic value against c-erbB-2, cathepsin-D and clinicopathological characteristics using univariate and multivariate analysis.
Scorilas A; Trangas T; Yotis J; Pateras C; Talieri M
Br J Cancer; 1999 Dec; 81(8):1385-91. PubMed ID: 10604737
[TBL] [Abstract][Full Text] [Related]
12. Amplification of c-erbB-2 in gastric cancer: detection in formalin-fixed, paraffin-embedded tissue by fluorescence in situ hybridization.
Ooi A; Kobayashi M; Mai M; Nakanishi I
Lab Invest; 1998 Mar; 78(3):345-51. PubMed ID: 9520947
[TBL] [Abstract][Full Text] [Related]
13. c-myc and chromosome 8 centromere studies of ovarian cancer by interphase FISH.
Wang ZR; Liu W; Smith ST; Parrish RS; Young SR
Exp Mol Pathol; 1999 Jun; 66(2):140-8. PubMed ID: 10409442
[TBL] [Abstract][Full Text] [Related]
14. Quantitative detection of amplification of proto-oncogenes in breast cancer.
Chen Y; Dong J; Lu Y; McGee JO
Chin Med J (Engl); 1995 Nov; 108(11):849-54. PubMed ID: 8585979
[TBL] [Abstract][Full Text] [Related]
15. Amplification of c-myc, K-sam, and c-met in gastric cancers: detection by fluorescence in situ hybridization.
Hara T; Ooi A; Kobayashi M; Mai M; Yanagihara K; Nakanishi I
Lab Invest; 1998 Sep; 78(9):1143-53. PubMed ID: 9759658
[TBL] [Abstract][Full Text] [Related]
16. Topoisomerase IIalpha gene amplification in gastric carcinomas: correlation with the HER2 gene. An immunohistochemical, immunoblotting, and multicolor fluorescence in situ hybridization study.
Kanta SY; Yamane T; Dobashi Y; Mitsui F; Kono K; Ooi A
Hum Pathol; 2006 Oct; 37(10):1333-43. PubMed ID: 16949920
[TBL] [Abstract][Full Text] [Related]
17. Association of C-MYC amplification with progression from the in situ to the invasive stage in C-MYC-amplified breast carcinomas.
Robanus-Maandag EC; Bosch CA; Kristel PM; Hart AA; Faneyte IF; Nederlof PM; Peterse JL; van de Vijver MJ
J Pathol; 2003 Sep; 201(1):75-82. PubMed ID: 12950019
[TBL] [Abstract][Full Text] [Related]
18. c-myc amplification in hepatocellular carcinoma predicts unfavorable prognosis.
Abou-Elella A; Gramlich T; Fritsch C; Gansler T
Mod Pathol; 1996 Feb; 9(2):95-8. PubMed ID: 8657726
[TBL] [Abstract][Full Text] [Related]
19. [Correlation between DNA content and amplification of oncogenes (c-myc, L-myc, c-erbB-2) and correlation with prognosis in 143 cases of resected lung cancer].
Chiba W; Sawai S; Hanawa T; Ishida H; Matsui T; Kosaba S; Watanabe S; Hatakenaka R; Matsubara Y; Funatsu T
Gan To Kagaku Ryoho; 1993 Apr; 20(6):824-7. PubMed ID: 8098200
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray.
Wang Y; Wu MC; Sham JS; Zhang W; Wu WQ; Guan XY
Cancer; 2002 Dec; 95(11):2346-52. PubMed ID: 12436441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
